Division of Vascular Surgery, University of South Florida, Tampa, Fla; Division of Vascular Surgery, Johns Hopkins Medical Institutions, Baltimore, Md.
Department of Medicine, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
J Vasc Surg. 2020 May;71(5):1664-1673. doi: 10.1016/j.jvs.2019.07.092. Epub 2020 Mar 12.
To evaluate patterns of use and outcomes of arteriovenous fistulas and prosthetic grafts within racial categories in a large population based cohort of hemodialysis (HD) patients in the United States.
A retrospective analysis of white, black, and Hispanic patients in the prospectively maintained United States Renal Database System who had an autogenous fistula or prosthetic graft placed for HD access between January 2007 and December 2014 was performed. Analysis of variance, χ, t-tests, Kaplan-Meier, log-rank tests, multivariable logistic, and Cox regression analyses were used to evaluate maturation, patency, infection, and mortality.
This study of 359,942 patients, composed of 285,781 autogenous fistulas (79.4%) and 74,161 prosthetic grafts (20.6%) placed in 213,877 white (59.4%), 115,727 black (32.2%), and 30,338 Hispanic (8.4%) patients. There was a 11% increase in the risk-adjusted odds of HD catheter use as bridge to autogenous fistula placement in blacks (adjusted odds ratio, 1.11; 95% confidence interval [CI], 1.08-1.14; P < .001) and a 9% increase in Hispanics (adjusted odds ratio, 1.09; 95% CI, 1.05-1.14; P < .001) compared with whites. Fistula maturation for HD access for whites vs blacks vs Hispanics was 77.0% vs 76.3% vs 77.8% (P = .35). After adjusting for covariates, fistula maturation was higher for blacks (adjusted hazard ratio, 1.09; 95% CI, 1.06-1.13; P < .001) and Hispanics (adjusted hazard ratio, 1.13; 95% CI, 1.06-1.20; P < .001) compared with whites. There was no significant difference in prosthetic graft maturation for blacks and Hispanics compared with whites. Primary, primary-assisted, and secondary patency were highest for Hispanic and least for black autogenous fistula recipients. Primary, primary-assisted, and secondary patency was also highest for Hispanic patients who received prosthetic grafts. Prosthetic grafts were associated with a decrease in patency and patient survival compared with fistulas in all racial categories. Mortality was lower for blacks and Hispanics relative to white patients. Initiation of HD with a catheter and conversion to autogenous fistula was associated with decrease in patency and patient survival compared with initiation with a fistula in all racial groups.
Autogenous fistulas are associated with better patency and patient survival compared with prosthetic grafts for all races studied. The use of HD catheter before fistula placement is more prevalent in Hispanic and black patients and is associated with worse patency and patient survival irrespective of race. Fistula and graft patency is highest for Hispanic patients. Patient survival is higher for Hispanic and black patients relative to whites. These associations suggest potential benefit with initiation of HD via autogenous fistula and minimizing temporizing catheter use, irrespective of race.
评估美国一个大型血液透析(HD)患者队列中,基于种族分类的动静脉瘘和人工移植物的使用模式和结局。
对 2007 年 1 月至 2014 年 12 月期间接受 HD 通路自体瘘或人工移植物置入的美国前瞻性维持的肾脏数据库系统中的白种人、黑种人和西班牙裔患者进行回顾性分析。采用方差分析、卡方检验、t 检验、Kaplan-Meier 分析、对数秩检验、多变量逻辑回归和 Cox 回归分析评估成熟度、通畅性、感染和死亡率。
这项研究共纳入 359942 名患者,其中 285781 例为自体瘘(79.4%),74161 例为人工移植物(20.6%),分别放置在 213877 例白种人(59.4%)、115727 例黑种人(32.2%)和 30338 例西班牙裔(8.4%)患者中。与白人相比,黑人(调整后的优势比,1.11;95%置信区间[CI],1.08-1.14;P <.001)和西班牙裔(调整后的优势比,1.09;95%CI,1.05-1.14;P <.001)接受 HD 导管作为自体瘘放置桥接的风险调整后可能性增加了 11%。白人、黑人、西班牙裔患者的 HD 通路自体瘘成熟度分别为 77.0%、76.3%和 77.8%(P =.35)。调整协变量后,黑人(调整后的危险比,1.09;95%CI,1.06-1.13;P <.001)和西班牙裔(调整后的危险比,1.13;95%CI,1.06-1.20;P <.001)的自体瘘成熟度更高。黑人(调整后的危险比,1.09;95%CI,1.06-1.13;P <.001)和西班牙裔(调整后的危险比,1.13;95%CI,1.06-1.20;P <.001)的人工移植物成熟度与白人相比无显著差异。与白人相比,黑人及西班牙裔患者的自体动静脉瘘初始通畅率、辅助通畅率和二级通畅率最高。西班牙裔患者的初始通畅率、辅助通畅率和二级通畅率也最高,且接受人工移植物治疗。与自体瘘相比,人工移植物与所有种族类别的通畅率和患者生存率降低相关。黑人及西班牙裔患者的死亡率低于白人。与自体瘘相比,所有种族患者开始接受 HD 治疗时使用导管且转为自体瘘的方式与通畅率和患者生存率降低相关。
与所有研究种族的人工移植物相比,自体瘘与更好的通畅率和患者生存率相关。与自体瘘相比,在 HD 通路建立前使用导管在西班牙裔和黑种人中更为常见,且与种族无关,其通畅率和患者生存率更差。西班牙裔患者的瘘和移植物通畅率最高。与白人相比,黑人及西班牙裔患者的生存率更高。这些关联表明,无论种族如何,通过自体瘘开始 HD 治疗并尽量减少临时导管使用,都可能带来益处。